Two decades after Rutgers scientists began working with Paul Janssen, a legendary drug developer and founder of Johnson & Johnson subsidiary Janssen Pharmaceutica, to create new and potent drugs to fight AIDS, the FDA has approved the second anti-HIV drug that came from this collaboration.
-For a drug to successfully make it to the finish line, countless obstacles must be overcome,- said Board of Governors Professor of Chemistry and Chemical Biology Eddy Arnold, who led the Rutgers team of scientists. -As a researcher in biomedical sciences I can tell you that helping to create new medicines is something you always dream about.
Posts
